-
公开(公告)号:US20170233383A1
公开(公告)日:2017-08-17
申请号:US15514584
申请日:2015-09-25
申请人: Zachary E. DANCE , Scott TRZASKA , Yong LIU , Richard John VARSOLONA , Gregory YORK , Merck Sharp & Dohme Corp.
IPC分类号: C07D417/12 , C07C309/30
CPC分类号: C07D417/12 , C07B2200/13 , C07C309/30
摘要: The present invention provides four crystalline forms of verubecestat, as well as pharmaceutically acceptable compositions thereof, each of which may be useful in treating, preventing, ameliorating, and/or delaying the onset of an Aβ pathology and/or a symptom or symptoms thereof. Non-limiting examples of such Aβ pathologies, including Alzheimer's disease, are disclosed herein.
-
公开(公告)号:US10017505B2
公开(公告)日:2018-07-10
申请号:US15514584
申请日:2015-09-25
IPC分类号: C07D417/12 , C07C309/30
CPC分类号: C07D417/12 , C07B2200/13 , C07C309/30
摘要: The present invention provides four crystalline forms of verubecestat, as well as pharmaceutically acceptable compositions thereof, each of which may be useful in treating, preventing, ameliorating, and/or delaying the onset of an Aβ pathology and/or a symptom or symptoms thereof. Non-limiting examples of such Aβ pathologies, including Alzheimer's disease, are disclosed herein.
-